• About
  • Team
  • Investor Info
  • Contact
  • More
    • About
    • Team
    • Investor Info
    • Contact
  • About
  • Team
  • Investor Info
  • Contact

Blood Test for Early Detection of Fatty Liver Disease

Highly accurate non-invasive blood test for early detection and assessment of Fatty Liver Disease through inflammatory lipid biomarkers

OUR LEADERSHIP

Andrew Dennis, MBA, Chief Executive Officer

Andrew Dennis, MBA, Chief Executive Officer

Andrew Dennis, MBA, Chief Executive Officer

(Formerly)


Quest Diagnostics

Growth Programs


Reveal Biosciences

Business Development


Dexcom

Chemistry R&D

Edward Dennis, PhD, Co-Founder

Andrew Dennis, MBA, Chief Executive Officer

Andrew Dennis, MBA, Chief Executive Officer

Distinguished Professor of Chemistry, Biochemistry, and Pharmacology at UC San Diego


Founder of LIPID Metabolites And Pathways Strategy (LIPID MAPS®)

Rohit Loomba, MD, MHsc, Co-Founder

Andrew Dennis, MBA, Chief Executive Officer

Rohit Loomba, MD, MHsc, Co-Founder

Professor of Medicine at UC San Diego


Founding Director, MASLD Research Center, UC San Diego


Chief, Gastroenterology and Hepatology, UC San Diego Health

Investor Info

Request Investor Materials - provide contact information to receive via email

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact Us

Contact partnering@liponexus.com to discuss investment, partnerships, and other opportunities in medicine, clinical trials, and companion diagnostics

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept